TriSalus Life Sciences, Inc. TLSI Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$39.23M-30.6% | -$30.05M+49.4% | -$59.36M-25.8% | -$47.19M-1,090% | ||
| $626K-15.9% | $744K+8.8% | $684K+71.9% | $398K— | ||
| $9.13M+67.8% | $5.44M+288% | $1.4M— | —— | ||
| $1.05M+71.4% | $612K— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | $1.72M-13.1% | $1.98M+890% | $200K— | ||
| -$971K-165% | $1.5M— | —— | —— | ||
| $2.02M+143% | -$4.69M-265% | $2.84M-45.9% | $5.25M— | ||
| —— | —— | —— | $2.59M+844% | ||
| $429K+62.5% | $264K+30.7% | $202K— | —— | ||
| -$134K+51.8% | -$278K+1.1% | -$281K— | —— | ||
| $2.74M+123% | -$12.06M— | —— | $0— | ||
| -$18.01M+55.9% | -$40.84M+19.2% | -$50.58M-56.5% | -$32.31M-1,759% | ||
| —— | $345K-41.3% | $588K— | —— | ||
| —— | $0— | —— | —— | ||
| —— | -$345K+78.3% | -$1.59M+11.1% | -$1.79M-3,077% | ||
| —— | $15.1M— | $0— | —— | ||
| $81K-3.6% | $84K-3.4% | $87K— | —— | ||
| —— | $2.6M— | —— | —— | ||
| $30.76M-18.9% | $37.94M-30.6% | $54.63M+306% | $13.46M+2,375% | ||
| —— | -$3.25M— | —— | -$20.66M-1,721% | ||
| $3.7M+110% | $1.76M+9,661% | $18K— | —— | ||
| —— | $18K+28.6% | $14K+55.6% | $9K— | ||
| —— | $187K— | —— | —— | ||
| $1.05M+71.4% | $612K— | —— | —— | ||
| $2.74M+123% | -$12.06M— | —— | $0— | ||
| -$4.1M— | —— | -$10.86M-397% | -$2.19M— | ||
| -$134K+51.8% | -$278K+1.1% | -$281K— | —— | ||
| —— | —— | —— | $2.59M+844% | ||
| $429K+62.5% | $264K+30.7% | $202K— | —— | ||
| —— | —— | —— | —— | ||
| —— | $0— | —— | —— | ||
| $81K-3.6% | $84K-3.4% | $87K— | —— | ||
| —— | $2.6M— | —— | —— | ||
| $404K-6.7% | $433K— | —— | —— | ||
| —— | $0-100% | $19K+58.3% | $12K— | ||
| $0-100% | $11.92M— | $0— | —— | ||
| —— | $0— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$134K+51.8% | -$278K+1.1% | -$281K— | —— | ||
| —— | —— | —— | —— | ||
| —— | $0— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | $18K+28.6% | $14K+55.6% | $9K— | ||
| -$18.93M+54.0% | -$41.19M+19.5% | -$51.17M— | —— | ||
| -$18.93M+54.0% | -$41.19M+19.5% | -$51.17M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TriSalus Life Sciences, Inc. generate?
- TriSalus Life Sciences, Inc. (TLSI) generated -$20.0M in operating cash flow over the trailing twelve months.
- What is TriSalus Life Sciences, Inc.'s free cash flow?
- After $1.2M of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$20.3M over the trailing twelve months, up 42.8% year over year.
- Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
